BOS-172722 |
| Catalog No.GC32846 |
Le BOS-172722 est un inhibiteur du point de contrÔle du fuseau monopolaire 1 (MPS1) avec une IC50 de 11 nM et 63 nM pour MPS1 (1 mM ATP) et P-MPS1, respectivement. Le BOS-172722 a également un potentiel pour l'étude de diverses formes de cancer du sein.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1578245-44-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
BOS-172722 is an inhibitor of monopolar spindle 1 (MPS1) checkpoint with an IC50 of 2 nM.
BOS-172722 is an inhibitor of monopolar spindle 1 (MPS1) checkpoint with an IC50 of 2 nM. BOS-172722 also has potential for the treatment of various forms of breast cancer[1].
[1]. ARYL SULFONOHYDRAZIDES. WO 2014037750 A1.
Average Rating: 5 (Based on Reviews and 7 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *